10 mg
Trade Name
Xyvora XL
Prolonged-release tablet
Request Type
New Registration
Drug Type
Generic(Multisource) Drug
Approval Date
SFDA Approved Use
Used to treat the symptoms of Benign Prostatic Hyperplasia (BPH).
As an adjunct therapy in connection with catheterisation in acute urinary retention (AUR) related to BPH.
As an adjunct therapy in connection with catheterisation in acute urinary retention (AUR) related to BPH.